FDA Unveils Groundbreaking Dashboard for Real-Time Reporting of Cosmetic Product Adverse Events
On September 30, 2025, the U.S. Food and Drug Administration (FDA) introduced a new interactive tool, the FDA Adverse Event […]
On September 30, 2025, the U.S. Food and Drug Administration (FDA) introduced a new interactive tool, the FDA Adverse Event […]
Attention clinical, quality, and regulatory professionals: the International Medical Device Regulators Forum (IMDRF) is making it easier for stakeholders to
On September 30, 2025, the FDA spotlighted the resources designed to help medical device professionals stay informed about recalls, market
The Medicines and Healthcare products Regulatory Agency (MHRA) has released its latest safety advice for August 2025, addressing crucial updates
The U.S. Food and Drug Administration (FDA) has taken a groundbreaking step by granting accelerated approval to Forzinity (elamipretide) injection
The International Medical Device Regulators Forum (IMDRF) has announced updates from its Working Groups, which are now available for review
On September 29, 2025, the FDA announced the expansion of its Early Alert program. This initiative is designed to improve
Field Safety Notices issued between August 25 and 29, 2025, provide crucial updates for stakeholders involved in medical device oversight.
The International Medical Device Regulators Forum (IMDRF) held a two-part workshop on September 11 and September 19, 2024, concentrating on
An updated communication from the FDA highlights significant concerns regarding BD Alaris Infusion Sets’ performance under particular use conditions. Clinical,